In September 2022 CSL presented the new R&D campus in Marburg. The new facility will be CSL’s largest R&D site under one roof, with more than 500 team members working in a state-of-the-art facility offering access to promising scientific partners and talent. 800 sqm of the lab space is dedicated to external collaborations with biotech startups.
Our guest is Vicky Pirzas who is the Managing Director of CSL Behring Innovation and VP of Recombinant Product Development. In addition to Vicky’s leadership of the global Recombinant and Viral vector development at CSL and she is driving the M600 R&D campus project in Marburg. Vicky is passionate about creating innovative ecosystems and new technologies.
CSL Behring
Vicky has been an employee with CSL for 7 years in Germany. Since joining CSL, Vicky has held increasingly senior positions in Recombinant Product development. In her current role, Vicky leads the global Recombinant and Viral vector development, is leading the M600 R&D campus project and is one of the Managing directors of CSL Behring Innovation.
Prior to joining CSL, Vicky has hel…
CrystalsFirst / DEEP Ecosystems / GründerVirus
Chapter Director
View Profile